From Innovation to Market Adoption: How Commercialisation Shapes the Journey?
Life Sciences Industry Panel Discussions Thursday, 24 September 2026 16:00-18:45 · Paris
As Novoptim marks its 20th anniversary, we are bringing together leaders from across the life sciences industry for two panel discussions exploring how the sector has evolved, and what will shape its future.
PANEL 1
Twenty Years of Life Science Commercialisation: What Changed, What Did Not, and What Comes Next?
Tim Germann
Chief Commercial Officer
Carterra, Inc.
Florence Genet
Global Vice-President Marketing & Sales
PeptiSystems AB
Xavier Morge
President
Porsolt
Shrikant Rahalkar
VP, LifeSciences Strategic Sales & Market Development LifeNet Health
Manuela Beil-Peter
Division Manager Europe LH/LS Analytik Jena
Harry Boeltz
Manager Sales Liquid Handling Sales Force EU Dispendix GmbH
PANEL 2
From Innovation to Standard Practice: What Drives Change, Who Shapes Adoption, and What Makes It Last?
Philippe Mourere
Chief Executive Officer
Vector Laboratories
Robert Bell
Co-Founder & COO
Exciting Instruments
Sammy Datwani
Co-Founder & CEO Prisma Bio
François Lehembre
Global Head Oncology Research Servier
Iris Maréchal
Co-Founder & CEO
Theremia
Rony Thomas
President & CEO
LifeNet Health
Jérôme Galon
Director of Research (DRCE)
Laboratory of Integrative Cancer Immunology, INSERM
Special Presentation Oncology in the era of immunotherapy
Jérôme Galon
Director of Research (DRCE),
Laboratory of Integrative Cancer Immunology, INSERM
Panel Discussions Registration Form
Seats are limited and registrations will be confirmed by email.
